Pharma conferences take center stage this week. AZN AstraZeneca presents today alongside NVS Novartis at industry gatherings. The $284B and $281B drugmakers anchor a packed healthcare schedule.
GS Goldman Sachs hosts banking conferences as financial services sector faces Iran war volatility. The $256B investment bank joins European peers navigating oil price chaos. Crude spiked above $95 as Strait of Hormuz closure persists.
GSK GSK rounds out today's $100B+ names with multiple investor meetings scheduled. The UK pharma giant holds $103B market cap amid sector rotation flows.
FT reported Trump signaled de-escalation in Iran talks sending markets higher. Oil tumbled on constructive dialogue headlines. Traders placed $580M in bets minutes before the Truth Social post dropped.
Zero confirmed earnings releases appear this week. Conference season dominates as executives brief analysts amid geopolitical uncertainty. No IPOs filed showing capital markets remain frozen.
European markets rebounded today after weeks of energy-driven losses. Gilt yields surged to 2008 highs as Bank of England rate hike bets intensified. Four increases now priced for 2026.
Healthcare and financial conferences fill calendars through Friday as executives address macro headwinds.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
